長時間作用性注射剤のアジア市場：市場規模・シェア・価格・動向・予測

• 英文タイトル：Asia Pacific Long-Acting Injectables Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

• レポートコード：D0FB0637186 • 出版社/出版日：Prof Research / 2019年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥420,000 (USD3,000)	▷ お問い合わせ
Site License	￥532,000 (USD3,800)	▷ お問い合わせ
Global Site License	￥700,000 (USD5,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

長時間作用性注射剤のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は長時間作用性注射剤の市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおける長時間作用性注射剤市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。 ・市場概要 ・産業チェーン分析（ファイブフォース分析、コスト構造分析） ・市場動向 ・長時間作用性注射剤のアジア市場規模推移2014-2019 ・長時間作用性注射剤のアジア市場規模予測2019-2024 ・長時間作用性注射剤のサプライヤー分析 ・顧客（需要先）分析 ・主要企業分析（Eli Lilly、Pfizer、GlaxoSmithKline、Johnson & Johnson、Lupin Limited、Zogenix、DURECT、Medincel） ・結論

Abstract:

The Asia Pacific Long-Acting Injectables market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.

This report is an essential reference for who looks for detailed information on Asia Pacific Long-Acting Injectables market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Long-Acting Injectables market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.

Key Points of this Report:

* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of Long-Acting Injectables
* It describes present situation, historical background and future forecast
* Comprehensive data showing Long-Acting Injectables capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on Long-Acting Injectables manufacturers
* Long-Acting Injectables market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us

The largest vendors of Asia Pacific Long-Acting Injectables market: (At least 8 companies included)
* Eli Lilly
* Pfizer
* GlaxoSmithKline
* Johnson & Johnson
* Lupin Limited
* Zogenix
For complete list, please ask for sample pages.

The Long-Acting Injectables market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand

The reports analysis Long-Acting Injectables market in Asia Pacific by products type:
* Type I
* Type II
* Type III

The reports analysis Long-Acting Injectables market in Asia Pacific by application as well:
* Application I
* Application II
* Application III

Reasons to Purchase this Report:

* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

レポート目次

---

Table of Contents

Chapter One Long-Acting Injectables Overview
1.1 Long-Acting Injectables Outline
1.2 Classification and Application
1.3 Manufacturing Technology

Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis

Chapter Three Market Dynamics of Long-Acting Injectables Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges

Chapter Four Asia Pacific Market of Long-Acting Injectables (2014-2019)
4.1 Long-Acting Injectables Supply
4.2 Long-Acting Injectables Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis

Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 Long-Acting Injectables Supply
5.2 Long-Acting Injectables Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis

Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation

Chapter Seven Asia Pacific Long-Acting Injectables Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis

Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 Eli Lilly
8.2 Pfizer
8.3 GlaxoSmithKline
8.4 Johnson & Johnson
8.5 Lupin Limited
……
……

Chapter Nine Research Conclusions of Asia Pacific Long-Acting Injectables Industry

Tables and Figures

Figure Commercial Product of Long-Acting Injectables
Table Classification of Long-Acting Injectables
Table Application of Long-Acting Injectables
Figure Porter Five Forces Model Analysis of Asia Pacific Long-Acting Injectables
Figure Production Cost Analysis of Asia Pacific Long-Acting Injectables
Table Long-Acting Injectables Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific Long-Acting Injectables Capacity List
Table 2014-2019 Asia Pacific Long-Acting Injectables Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific Long-Acting Injectables Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific Long-Acting Injectables Key Manufacturers Production List
Table 2014-2019 Asia Pacific Long-Acting Injectables Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific Long-Acting Injectables Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific Long-Acting Injectables Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific Long-Acting Injectables Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific Long-Acting Injectables Production Value and Growth Rate
Table 2014-2019 Asia Pacific Long-Acting Injectables Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific Long-Acting Injectables Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of Long-Acting Injectables
Table 2014-2019 Asia Pacific Import and Export of Long-Acting Injectables
Table 2014-2019 Asia Pacific Long-Acting Injectables Demand List by Application
Figure 2014-2019 Asia Pacific Long-Acting Injectables Demand by Application
Table 2014-2019 Asia Pacific Long-Acting Injectables Demand Share List by Application
Figure 2014-2019 Asia Pacific Long-Acting Injectables Demand Share by Application
Table 2014-2019 Asia Pacific Long-Acting Injectables Country-wise Consumption List
Figure 2014-2019 Asia Pacific Long-Acting Injectables Country-wise Consumption
Table 2014-2019 Asia Pacific Long-Acting Injectables Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific Long-Acting Injectables Country-wise Consumption Share
Table 2014-2019 Asia Pacific Long-Acting Injectables Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific Long-Acting Injectables Capacity List
Table 2019-2024 Asia Pacific Long-Acting Injectables Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific Long-Acting Injectables Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific Long-Acting Injectables Key Manufacturers Production List
Table 2019-2024 Asia Pacific Long-Acting Injectables Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific Long-Acting Injectables Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific Long-Acting Injectables Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific Long-Acting Injectables Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of Long-Acting Injectables
Table 2019-2024 Asia Pacific Import and Export of Long-Acting Injectables
Table 2019-2024 Asia Pacific Demand of Long-Acting Injectables by Application
Figure 2019-2024 Asia Pacific Long-Acting Injectables Demand by Application
Table 2019-2024 Asia Pacific Long-Acting Injectables Demand Share List by Application
Figure 2019-2024 Asia Pacific Long-Acting Injectables Demand Share by Application
Table 2019-2024 Asia Pacific Long-Acting Injectables Country-wise Consumption List
Figure 2019-2024 Asia Pacific Long-Acting Injectables Country-wise Consumption
Table 2019-2024 Asia Pacific Long-Acting Injectables Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific Long-Acting Injectables Country-wise Consumption Share
Table 2019-2024 Asia Pacific Long-Acting Injectables Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific Long-Acting Injectables Raw Material Suppliers
Table Key End Users List
Table Profile of Eli Lilly
Table SWOT Analysis of Eli Lilly
Table Eli Lilly Long-Acting Injectables Product Specification
Table 2014-2019 Eli Lilly Long-Acting Injectables Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Eli Lilly Long-Acting Injectables Capacity Production and Growth Rate
Figure 2014-2019 Eli Lilly Long-Acting Injectables Production Global Market Share
Table SWOT Analysis of Pfizer
Figure Pfizer Long-Acting Injectables Products
Table 2014-2019 Pfizer Long-Acting Injectables Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Pfizer Long-Acting Injectables Capacity Production and Growth Rate
Figure 2014-2019 Pfizer Long-Acting Injectables Production Global Market Share
Table SWOT Analysis of GlaxoSmithKline
Figure GlaxoSmithKline Long-Acting Injectables Product
Table GlaxoSmithKline Long-Acting Injectables Product Specification
Table 2014-2019 GlaxoSmithKline Long-Acting Injectables Product Capacity Production Price Cost Production Value List
Figure 2014-2019 GlaxoSmithKline Long-Acting Injectables Capacity Production and Growth Rate
Figure 2014-2019 GlaxoSmithKline Long-Acting Injectables Production Global Market Share
Table Profile of Johnson & Johnson
Table SWOT Analysis of Johnson & Johnson
Figure Johnson & Johnson Long-Acting Injectables Product
Table Johnson & Johnson Long-Acting Injectables Product Specification
Table 2014-2019 Johnson & Johnson Long-Acting Injectables Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Johnson & Johnson Long-Acting Injectables Capacity Production and Growth Rate
Figure 2014-2019 Johnson & Johnson Long-Acting Injectables Production Global Market Share
Table Profile of Lupin Limited
Table SWOT Analysis of Lupin Limited
Figure Lupin Limited Long-Acting Injectables Product
Table 2014-2019 Lupin Limited Long-Acting Injectables Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Lupin Limited Long-Acting Injectables Capacity Production and Growth Rate
Figure 2014-2019 Lupin Limited Long-Acting Injectables Production Global Market Share
……
……

---